Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background And Aims: Organic anion-transporting polypeptides (OATPs) play a crucial role in the transport of bile acids and bilirubin. In our previous study, interleukin 6 (IL-6) reduced OATP1B3 levels in cholestatic disease. However, it remains unclear whether IL-6 inhibits OATP1B1 expression in cholestatic diseases. This study aimed to investigate whether IL-6 can inhibit OATP1B1 expression and explore the underlying mechanisms.
Methods: The effect of stimulator of interferon genes (STING) signaling on inflammatory factors was investigated in a cholestatic mouse model using RT-qPCR and enzyme-linked immunosorbent assay. To assess the impact of inflammatory factors on OATP1B1 expression in hepatocellular carcinoma, we analyzed OATP1B1 expression by RT-qPCR and Western Blot after treating PLC/PRF/5 cells with TNF-α, IL-1β, and IL-6. To elucidate the mechanism by which IL-6 inhibits OATP1B1 expression, we examined the expression of the OATP1B1 regulator TCF4 in PLC/PRF/5 and HepG2 cells using RT-qPCR and Western Blot. The interaction mechanism between β-catenin/TCF4 and OATP1B1 was investigated by knocking down β-catenin/TCF4 through siRNA transfection.
Results: The STING inhibitor decreased inflammatory factor levels in the cholestatic mouse model, with IL-6 exhibiting the most potent inhibitory effect on OATP1B1. IL-6 downregulated β-catenin/TCF4, leading to decreased OATP1B1 expression. Knocking-down β-catenin/TCF4 counteracted the β-catenin/TCF4-mediated repression of OATP1B1.
Conclusions: STING-mediated IL-6 up-regulation may inhibit OATP1B1, leading to reduced transport of bile acids and bilirubin by OATP1B1. This may contribute to altered pharmacokinetics in patients with diseases associated with increased IL-6 production.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11310758 | PMC |
| http://dx.doi.org/10.14218/JCTH.2024.00017 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Regulation of hepatic organic anion transporting polypeptide 1B-type transport function by the protein kinase LYN.
Drug Metab Dispos
July 2025
Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, Division of Molecular Biosciences, University at Buffalo, Buffalo, New York. Electronic address:
Src family kinases, including the Lck/Yes-related novel protein kinase (LYN), have emerged as posttranslational modulators of various transporters involved in clinically relevant pharmacokinetic drug-drug interactions. LYN expression was recently detected in hepatocytes, and we hypothesized that LYN deficiency alters the phosphorylation status and activity of transporters involved in hepatic drug disposition. An untargeted phospho-proteomic screen in livers of mice revealed that LYN deficiency was associated with significantly reduced phosphorylation of the hepatic uptake organic anion transporting polypeptide Oatp1b2 transporter that recognizes a wide range of structurally diverse xenobiotics.
View Article and Find Full Text PDFRoles of organic anion transporting polypeptides in hepatocellular carcinoma.
Front Genet
July 2025
College of Arts and Science, Vanderbilt University, Nashville, TN, United States.
Introduction: Hepatocellular carcinoma (HCC) is the most common primary liver malignancy, predominantly occurring in patients with underlying chronic liver disease, including cirrhosis. Organic anion transporter polypeptides (OATPs), encoded by SLCO genes, are one of the most important SLC subfamilies involved in the cellular uptake of drugs and endobiotic. OATP1B1 (SLCO1B1 gene), OATP1B3 (SLCO1B3 gene), and OATP2B1 (SLCO2B1 gene) are hepatic uptake transporters highly expressed in the liver.
View Article and Find Full Text PDFThe Effect of Radixin on the Function and Expression of Organic Anion Transporting Polypeptide 1B1.
Biology (Basel)
June 2025
College of Life Sciences, South China Agricultural University, Guangzhou 510642, China.
Organic anion transporting polypeptide 1B1 (OATP1B1) is selectively expressed at the basolateral membrane of human hepatocytes and plays a crucial role in the absorption of various xenobiotic compounds, including many important clinical drugs. Oligomerization with regulatory proteins is a common mechanism for regulating membrane protein functions. In the present study, we found that knocking down the scaffold protein radixin, which is the major member of the ERM family expressed in the liver, significantly enhanced the uptake function of OATP1B1.
View Article and Find Full Text PDFRegulation of expression and activity of hepatic transporters by pregnancy-related hormones in HepaRG cells.
Drug Metab Dispos
August 2025
Department of Pharmaceutics, University of Washington, Seattle, Washington. Electronic address:
Although pregnancy induces changes in in vivo hepatic metabolic activity, little is known about its effects on hepatic transporter activity. Previously, we showed that pregnancy-related hormones (PRH) induce mRNA expression and/or activity of hepatic transporters, sodium taurocholate cotransporting polypeptide (NTCP), organic anion transporter 2 (OAT2), and organic cation transporter 1 (OCT1) in plated human hepatocytes (PHH). However, PHH cannot be readily used to determine the mechanisms of regulation of hepatic transporters by PRH.
View Article and Find Full Text PDFComparative study of multidrug resistance-targeting 8-hydroxyquinoline-amino acid conjugates: anticancer effect, interaction with human serum albumin and organic anion transporting polypeptides.
Eur J Pharm Sci
September 2025
Department of Molecular and Analytical Chemistry, Interdisciplinary Excellence Centre, University of Szeged, Dóm tér 7-8, H-6720 Szeged, Hungary.
There is a significant demand for the development of targeted and effective treatments for drug-resistant cancer. We have formerly developed several 8-hydroxyquinoline Mannich base compounds whose toxicity is actually enhanced, rather than diminished on multidrug resistant cancer cells. The scope of our work is to provide comprehensive data on the cytotoxicity of D/L-5‑chloro- or 5-nitro substituted 7-((homo)proline-1-ylmethyl)quinolin-8-ol compounds on cocultured parental (MES-SA) and ABCB1-expressing MDR (MES-SA/Dx5 and MES-SA/B1) uterine sarcoma cancer cells, to determine the inhibitory effect on organic anion transporting polypeptides (OATPs) OATP1B1 and OATP2B1, and to characterize the solution chemical and human serum albumin (HSA) binding properties of these molecules, thus assessing certain main pharmacokinetic descriptors in absorption and distribution.
View Article and Find Full Text PDF